Related Experiment Video
Updated: Apr 17, 2026

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
Published on: August 28, 2018
C-Reactive Protein-Triglyceride-Glucose Index and Coronary Artery Calcium Progression: A Prospective Cohort Analysis
Qing-Yun Hao1, Ze-Hua Li2, Jun Weng2
1Department of Cardiology, The affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
Objective:
The C-reactive protein-triglyceride-glucose index (CTI) reflects systemic inflammation and insulin resistance, but its relationship with coronary artery calcium (CAC) progression remains unclear. This study examined the association between CTI and CAC progression in a longitudinal cohort.
Methods:
Participants from the Coronary Artery Risk Development in Young Adults (CARDIA) study with CAC measurements at years 15, 20, and 25 were included. CTI was calculated from fasting blood samples at year 15 and categorized into quartiles. CAC was quantified using standardized computed tomography. CAC progression was defined as incident CAC > 0 for those with baseline CAC = 0, an annualized CAC increase ≥ 10 units for those with baseline CAC: 0-100, or an annualized percent increase ≥10% for those with baseline CAC ≥ 100. Cox proportional hazards models estimated hazard ratios (HRs), adjusting for cardiovascular risk factors.
Results:
Among 2655 participants (mean age 40.3 ± 3.6 years; 44.7% men), 704 (26.5%) experienced CAC progression over 8.9 ± 2.0 years. After adjustment, individuals in the highest CTI quartile had a 38% higher risk of CAC progression compared with the lowest quartile (HR = 1.380; 95% CI: 1.072-1.775). Subgroup analyses by age, sex, race, body mass index, and baseline CAC status were consistent, and results remained robust after excluding participants with baseline diabetes or lipid-lowering medication use.
Conclusions:
Higher CTI was independently associated with increased CAC progression, supporting its potential utility as a biomarker for identifying individuals at elevated risk of subclinical atherosclerosis.
Trial Registration:
URL: https://www.
Clinicaltrials:
gov; Unique identifier: NCT00005130.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
06:57Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection
Published on: September 22, 2023
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease I: Introduction
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease V: Interprofessional Care